Columbia University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1754-01-01

Employees: 20.8K

Market Cap: -

Website: https://www.arch.columbia.edu

Clinical Trials

Value of 3D Modeling in Spine Surgery

Not Applicable

Terminated

Conditions: Scoliosis

Interventions: Device: spineEOS software
Device: EOS

First Posted Date: 2016-05-13

Last Posted Date: 2024-07-31

Lead Sponsor: Columbia University

Target Recruit Count: 54

Registration Number: NCT02771899

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Effects of Sleep Restriction on BAT Activation in Humans

Not Applicable

Completed

Conditions: Sleep Deprivation
Obesity

Interventions: Behavioral: Partial Sleep Restriction
Behavioral: Total Sleep Deprivation
Behavioral: Habitual Sleep

First Posted Date: 2016-05-12

Last Posted Date: 2017-07-19

Lead Sponsor: Columbia University

Target Recruit Count: 4

Registration Number: NCT02770118

Locations: 🇺🇸
New York Nutrition Obesity Research Center, New York, New York, United States

Closed Suction Drainage in Shoulder Arthroplasty

Not Applicable

Completed

Conditions: Osteoarthritis

Interventions: Procedure: Wound drainage
Procedure: Total Shoulder Arthroplasty

First Posted Date: 2016-05-10

Last Posted Date: 2019-03-27

Lead Sponsor: Columbia University

Target Recruit Count: 100

Registration Number: NCT02767453

Locations: 🇺🇸
Columbia University medical Center, New York, New York, United States

The Value of Home Chlorhexidine Pre-Surgical Wash Before Spine Surgery

Not Applicable

Completed

Conditions: Infection
Spinal Injuries

Interventions: Other: No intervention
Device: Chlorhexidine Wipes

First Posted Date: 2016-05-10

Last Posted Date: 2023-02-06

Lead Sponsor: Columbia University

Target Recruit Count: 40

Registration Number: NCT02767427

Locations: 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

Lesser Tuberosity Osteotomy for Subscapularis Repair

Not Applicable

Completed

Conditions: Osteoarthritis

Interventions: Procedure: TSA with lesser tuberosity osteotomy technique
Procedure: TSA with tenotomy technique
Device: Shoulder prosthesis

First Posted Date: 2016-05-05

Last Posted Date: 2024-08-06

Lead Sponsor: Columbia University

Target Recruit Count: 60

Registration Number: NCT02762903

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors

Phase 2

Terminated

Conditions: Pituitary Tumor
ACTH-producing Pituitary Tumour

Interventions: Drug: Pasireotide LAR

First Posted Date: 2016-04-22

Last Posted Date: 2021-04-27

Lead Sponsor: Columbia University

Target Recruit Count: 4

Registration Number: NCT02749227

Locations: 🇺🇸
Neuroendocrine Unit and Pituitary Center, Columbia University, New York, New York, United States

N-of-1 Trials for Blood Pressure Medications in Adults

Early Phase 1

Completed

Conditions: High Blood Pressure
Hypertension

Interventions: Drug: Losartan
Drug: Amlodipine
Drug: Hydrochlorothiazide

First Posted Date: 2016-04-20

Last Posted Date: 2019-03-26

Lead Sponsor: Columbia University

Target Recruit Count: 10

Registration Number: NCT02744456

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

iPhone Helping Evaluate Atrial Fibrillation Rhythm Through Technology

Not Applicable

Completed

Conditions: Atrial Fibrillation
Atrial Flutter

Interventions: Device: AliveCor
Behavioral: Behavioral Altering Messaging

First Posted Date: 2016-04-07

Last Posted Date: 2024-07-03

Lead Sponsor: Columbia University

Target Recruit Count: 264

Registration Number: NCT02731326

Locations: 🇺🇸
Columbia University Medical Center, New York, New York, United States

Web-based Validation Pelvic Floor Questionnaires

Completed

Conditions: Pelvic Floor Dysfunction

Interventions: Other: paper form
Other: web/smartphone form

First Posted Date: 2016-03-31

Last Posted Date: 2019-04-01

Lead Sponsor: Columbia University

Target Recruit Count: 90

Registration Number: NCT02724891

Locations: 🇺🇸
University of Arkansas, Fayetteville, Arkansas, United States
🇺🇸
University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States
🇨🇦
University of Calgary, Calgary, Alberta, Canada

and more 2 locations

Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC

Phase 2

Completed

Conditions: Carcinoma, Non-Small-Cell Lung

Interventions: Drug: MPDL3280A
Drug: Carboplatin
Drug: Nab-paclitaxel

First Posted Date: 2016-03-22

Last Posted Date: 2023-12-12

Lead Sponsor: Columbia University

Target Recruit Count: 39

Registration Number: NCT02716038

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Columbia University Irving Medical Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy